Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.

Setoguchi M, Hashimoto Y, Sasaoka T, Ashikaga T, Isobe M.

Heart Vessels. 2015 Sep;30(5):595-603. doi: 10.1007/s00380-014-0532-5. Epub 2014 Jun 17.

PMID:
24935218
2.

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.

Cheng RK, Cox M, Neely ML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC.

Am Heart J. 2014 Nov;168(5):721-30. doi: 10.1016/j.ahj.2014.07.008. Epub 2014 Jul 22.

PMID:
25440801
3.

Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.

Bavishi C, Ather S, Bambhroliya A, Jneid H, Virani SS, Bozkurt B, Deswal A.

Am J Cardiol. 2014 Jun 1;113(11):1834-8. doi: 10.1016/j.amjcard.2014.03.017. Epub 2014 Mar 18.

PMID:
24837261
4.

Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction.

Nichols GA, Reynolds K, Kimes TM, Rosales AG, Chan WW.

Am J Cardiol. 2015 Oct 1;116(7):1088-92. doi: 10.1016/j.amjcard.2015.07.018. Epub 2015 Jul 15.

PMID:
26235928
5.

Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.

Quiroz R, Doros G, Shaw P, Liang CS, Gauthier DF, Sam F.

Am J Cardiol. 2014 Feb 15;113(4):691-6. doi: 10.1016/j.amjcard.2013.11.014. Epub 2013 Nov 23.

PMID:
24484862
6.

Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.

Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, Watanabe M, Yao A, Hirata Y, Kazuma K, Nagai R.

J Cardiol. 2012 Jul;60(1):23-30. doi: 10.1016/j.jjcc.2012.01.010. Epub 2012 Mar 21.

7.

In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.

Senni M, Gavazzi A, Oliva F, Mortara A, Urso R, Pozzoli M, Metra M, Lucci D, Gonzini L, Cirrincione V, Montagna L, Di Lenarda A, Maggioni AP, Tavazzi L; IN HF Outcome Investigators..

Int J Cardiol. 2014 May 1;173(2):163-9. doi: 10.1016/j.ijcard.2014.02.018. Epub 2014 Feb 22.

PMID:
24630337
8.

Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.

Maeder MT, Kaye DM.

Int J Cardiol. 2012 Mar 8;155(2):249-56. doi: 10.1016/j.ijcard.2010.10.007. Epub 2010 Oct 28.

PMID:
21035207
9.

Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).

Marui A, Nishiwaki N, Komiya T, Hanyu M, Tanaka S, Kimura T, Sakata R; CREDO-Kyoto CABG Registry Cohort-2 Investigators..

Am J Cardiol. 2015 Aug 15;116(4):580-6. doi: 10.1016/j.amjcard.2015.05.020. Epub 2015 May 21.

PMID:
26092271
10.

Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.

Takada T, Sakata Y, Miyata S, Takahashi J, Nochioka K, Miura M, Tadaki S, Shimokawa H; CHART-2 Investigators..

Eur J Heart Fail. 2014 Mar;16(3):309-16. doi: 10.1002/ejhf.22. Epub 2013 Dec 31.

11.

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.

Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D.

Circ Heart Fail. 2013 Mar;6(2):279-86. doi: 10.1161/CIRCHEARTFAILURE.112.972828. Epub 2012 Dec 27.

12.

Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction.

Farasat SM, Bolger DT, Shetty V, Menachery EP, Gerstenblith G, Kasper EK, Najjar SS.

Am J Cardiol. 2010 Jan 15;105(2):229-34. doi: 10.1016/j.amjcard.2009.09.008.

PMID:
20102924
13.

Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.

Brunner-La Rocca HP, Eurlings L, Richards AM, Januzzi JL, Pfisterer ME, Dahlström U, Pinto YM, Karlström P, Erntell H, Berger R, Persson H, O'Connor CM, Moertl D, Gaggin HK, Frampton CM, Nicholls MG, Troughton RW.

Eur J Heart Fail. 2015 Dec;17(12):1252-61. doi: 10.1002/ejhf.401. Epub 2015 Sep 30.

14.

Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.

Salamon JN, Kelesidis I, Msaouel P, Mazurek JA, Mannem S, Adzic A, Zolty R.

J Card Fail. 2014 Jul;20(7):467-75. doi: 10.1016/j.cardfail.2014.05.003. Epub 2014 May 23.

PMID:
24858070
15.

How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.

Maisel AS, Shah KS, Barnard D, Jaski B, Frivold G, Marais J, Azer M, Miyamoto MI, Lombardo D, Kelsay D, Iqbal N, Taub PR, Kupfer K, Lee E, Clopton P, Zile M, Greenberg B.

J Card Fail. 2016 Apr;22(4):283-93. doi: 10.1016/j.cardfail.2015.09.014. Epub 2015 Oct 31.

PMID:
26433086
16.

Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.

Lok DJ, Klip IT, Voors AA, Lok SI, Bruggink-André de la Porte PW, Hillege HL, Jaarsma T, van Veldhuisen DJ, van der Meer P.

Eur J Heart Fail. 2014 Sep;16(9):958-66. doi: 10.1002/ejhf.140. Epub 2014 Jul 31.

17.

Sex differences in clinical characteristics and long-term outcome in acute decompensated heart failure patients with preserved and reduced ejection fraction.

Nakada Y, Kawakami R, Nakano T, Takitsume A, Nakagawa H, Ueda T, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Okura H, Saito Y.

Am J Physiol Heart Circ Physiol. 2016 Apr 1;310(7):H813-20. doi: 10.1152/ajpheart.00602.2015. Epub 2016 Jan 8.

18.

Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H; JCARE-CARD Investigators..

Circ J. 2009 Oct;73(10):1893-900. Epub 2009 Jul 31. Erratum in: Circ J. 2009 Dec;73(12):2365.

19.

Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S; ALLHAT Collaborative Research Group..

Circulation. 2008 Nov 25;118(22):2259-67. doi: 10.1161/CIRCULATIONAHA.107.762229. Epub 2008 Nov 10.

20.

Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.

Nadruz W Jr, West E, Santos M, Skali H, Groarke JD, Forman DE, Shah AM.

Circ Heart Fail. 2016 Apr;9(4):e002826. doi: 10.1161/CIRCHEARTFAILURE.115.002826.

Supplemental Content

Support Center